T5B-21791-22339
4 vaccinations
1 coded response
51 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 945 / CA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
BM4-26797-33820
Child or adolescent in my care · Female · 2022-09-08
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Moderna
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-04-19
Dose 2 — Moderna
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-18
-
2021-10-25
Dose 3 — Moderna
- 2021-10-25
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2022-01-24
-
2022-04-25
Survey response — 6 months, dose 3MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Postpartum preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-26
-
2022-09-04
Dose 4 — Moderna
- 2022-09-06
- 2022-09-08
- 2022-09-09
- 2022-09-13
- 2022-09-18
- 2022-09-25
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-12-04
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna | |
| 3 | 2021-10-25 | Moderna | No |
| 4 | 2022-09-04 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 6 months, dose 3
Symptoms: Postpartum preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-eclampsia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release